1. Home
  2. PSFE vs AQST Comparison

PSFE vs AQST Comparison

Compare PSFE & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paysafe Limited

PSFE

Paysafe Limited

HOLD

Current Price

$6.78

Market Cap

475.6M

ML Signal

HOLD

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$4.71

Market Cap

529.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSFE
AQST
Founded
1996
2004
Country
United Kingdom
United States
Employees
2900
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
475.6M
529.4M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
PSFE
AQST
Price
$6.78
$4.71
Analyst Decision
Hold
Strong Buy
Analyst Count
4
5
Target Price
$8.69
$9.00
AVG Volume (30 Days)
279.9K
1.4M
Earning Date
05-13-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$67,430,000.00
Revenue This Year
$8.15
$10.08
Revenue Next Year
$6.25
$49.60
P/E Ratio
N/A
N/A
Revenue Growth
N/A
0.77
52 Week Low
$5.95
$2.94
52 Week High
$15.02
$7.55

Technical Indicators

Market Signals
Indicator
PSFE
AQST
Relative Strength Index (RSI) 39.21 69.80
Support Level $6.64 $3.74
Resistance Level $8.01 $5.02
Average True Range (ATR) 0.39 0.18
MACD -0.01 0.07
Stochastic Oscillator 10.32 96.64

Price Performance

Historical Comparison
PSFE
AQST

About PSFE Paysafe Limited

Paysafe Ltd is an integrated payments platform. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through capabilities in payment processing, digital wallet, and online cash solutions. The company's reportable segments are Merchant Solutions and Digital Wallets. The Merchant Solutions segment, which derives maximum revenue, services markets in North America, Canada and Europe. The Digital Wallets segment services markets in Europe, UK, North America and Latin America. It derives a majority of revenue from the USA followed by Germany, the UK, and all other countries.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: